The ethics of using safe gene therapies to improve the health and cognition of Down syndrome children and adults.
Kevin Esvelt, assistant professor at the MIT Media Lab, speaks to WSJ health and science reporter Amy Dockser Marcus about how far away we are from DNA editing and the ethical questions along the way.
We preselected all newsletters you had before unsubscribing.
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...
A growing body of research shows that cultural values strongly influence public attitudes toward CRISPR, with Japanese respondents focusing on legal frameworks and Americans on religious concerns.
CRISPR-Cas 9 is a gene-editing tool that made it possible to rewrite any organism's genetic code and tackle genetic diseases more effectively. Known as genetic scissors, CRISPR identifies a DNA ...
Like the human immune system, bacteria learn from past infections. CRISPR sequences—short snippets of DNA from previous viruses—guide destructive enzymes towards invading bacteriophages that express ...
CRISPR Therapeutics’ gene-editing treatments are highly customized and shockingly expensive. The market is watching to see if the underlying science can be applied to treat many diseases. The company ...
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...